Home Cart Sign in  
Chemical Structure| 1210945-69-9 Chemical Structure| 1210945-69-9

Structure of EG00229
CAS No.: 1210945-69-9

Chemical Structure| 1210945-69-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

EG00229 is the first small molecule inhibitor of the neuropilin-1 and VEGF-A interaction with an IC50 of inhibition of 8 μM(125I-VEGF binding to PAE/NRP1 cells).

Synonyms: EG 00229(trifluoroacetate salt); EG00229 trifluoroacetate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of EG00229

CAS No. :1210945-69-9
Formula : C19H20F3N7O7S3
M.W : 611.60
SMILES Code : N=C(N)NCCC[C@@H](C(O)=O)NC(C1=C(NS(=O)(C2=CC=CC3=NSN=C32)=O)C=CS1)=O.O=C(O)C(F)(F)F
Synonyms :
EG 00229(trifluoroacetate salt); EG00229 trifluoroacetate
MDL No. :MFCD28167995

Safety of EG00229

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of EG00229

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Dorsal root ganglion neurons 30 μM 30 min EG00229 inhibited VEGF-A-mediated increase in N-type calcium currents PMC7737878
Dorsal root ganglion neurons 30 μM 30 min EG00229 inhibited VEGF-A-mediated increase in sodium currents PMC7737878
Spinal dorsal horn neurons 30 μM 30 min EG00229 reduced VEGF-A-induced increase in spontaneous excitatory postsynaptic current frequency PMC7737878
Dorsal root ganglion neurons 30 μM 30 min EG00229 blocked VEGF-A-induced increase in spontaneous firing of DRG neurons PMC7737878
A549 lung carcinoma cells 100 μM 48 h Significantly reduced cell viability and enhanced the cytotoxic effects of paclitaxel and 5-fluorouracil. PMC2841442
Human umbilical vein endothelial cells (HUVECs) 100 μM 30 min Inhibited VEGF-A-induced VEGFR2 tyrosine phosphorylation with a maximum inhibition of 34%. PMC2841442

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Neuropathic pain model Intrathecal injection 2 mg (5μL) Single administration, observed for 5 hours EG00229 reversed nerve injury-induced mechanical allodynia PMC7737878
SCID mice 786-O xenograft model Intravenous injection 300 µg/kg 3 times per week for 3 weeks To evaluate the antitumor effect of EG00229 in the 786-O xenograft model, results showed that EG-L significantly inhibited tumor growth. PMC6895165

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.64mL

0.33mL

0.16mL

8.18mL

1.64mL

0.82mL

16.35mL

3.27mL

1.64mL

References

 

Historical Records

Categories